Organization
Neuron23
2 clinical trials
Clinical trial
A Phase 1, Single and Multiple Ascending Dose and Food Effect Study of NEU-411 Administered Orally to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2024-05-31
Clinical trial
A Phase 1, Single and Multiple Ascending Dose Study of NEU-723 Administered Orally to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy SubjectsStatus: Terminated, Estimated PCD: 2023-06-30